$5.66 Billion is the total value of Artal Group S.A.'s 148 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $463,516,000 | +28.2% | 14,818,300 | 0.0% | 8.19% | +5.5% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $417,817,000 | +71.6% | 71,178,364 | 0.0% | 7.38% | +41.3% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $295,868,000 | +14.5% | 850,000 | -15.0% | 5.23% | -5.8% |
| SEER | Sell | SEER INC | $279,530,000 | -14.8% | 5,588,366 | -4.3% | 4.94% | -29.8% |
| C | New | CITIGROUP INCcall | $218,250,000 | – | 3,000,000 | +100.0% | 3.86% | – |
| GM | New | GENERAL MTRS COcall | $201,110,000 | – | 3,500,000 | +100.0% | 3.55% | – |
| XLRN | ACCELERON PHARMA INC | $189,854,000 | +6.0% | 1,400,000 | 0.0% | 3.36% | -12.7% | |
| RUBY | Buy | RUBIUS THERAPEUTICS INC | $129,420,000 | +351.2% | 4,883,791 | +29.2% | 2.29% | +271.3% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $124,193,000 | +13.1% | 725,000 | +45.0% | 2.19% | -7.0% |
| ARGX | Buy | ARGENX SEsponsored adr | $123,926,000 | +40.5% | 450,000 | +50.0% | 2.19% | +15.6% |
| MORF | Buy | MORPHIC HLDG INC | $115,118,000 | +107.7% | 1,819,186 | +10.1% | 2.03% | +70.9% |
| FATE | Sell | FATE THERAPEUTICS INC | $107,185,000 | -15.8% | 1,300,000 | -7.1% | 1.89% | -30.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $105,893,000 | +1.8% | 750,000 | -6.2% | 1.87% | -16.2% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $101,320,000 | -0.6% | 2,000,000 | -4.8% | 1.79% | -18.2% |
| BNTX | Sell | BIONTECH SEsponsored ads | $98,271,000 | +20.5% | 900,000 | -10.0% | 1.74% | -0.8% |
| IGMS | Sell | IGM BIOSCIENCES INC | $86,276,000 | -18.6% | 1,125,000 | -6.2% | 1.52% | -33.0% |
| F | New | FORD MTR CO DELcall | $85,750,000 | – | 7,000,000 | +100.0% | 1.52% | – |
| INTC | New | INTEL CORPcall | $83,200,000 | – | 1,300,000 | +100.0% | 1.47% | – |
| GBIO | GENERATION BIO CO | $80,092,000 | +0.4% | 2,814,191 | 0.0% | 1.42% | -17.4% | |
| BAC | New | BK OF AMERICA CORPcall | $77,380,000 | – | 2,000,000 | +100.0% | 1.37% | – |
| TGTX | TG THERAPEUTICS INC | $72,300,000 | -7.3% | 1,500,000 | 0.0% | 1.28% | -23.8% | |
| XBI | New | SPDR SER TRcall | $67,825,000 | – | 500,000 | +100.0% | 1.20% | – |
| BMY | BRISTOL-MYERS SQUIBB COcall | $63,130,000 | +1.8% | 1,000,000 | 0.0% | 1.12% | -16.3% | |
| SDGR | SCHRODINGER INC | $60,837,000 | -3.7% | 797,445 | 0.0% | 1.08% | -20.7% | |
| ALVR | ALLOVIR INC | $54,367,000 | -39.1% | 2,323,371 | 0.0% | 0.96% | -49.9% | |
| INTC | New | INTEL CORP | $51,200,000 | – | 800,000 | +100.0% | 0.90% | – |
| AA | New | ALCOA CORPcall | $48,735,000 | – | 1,500,000 | +100.0% | 0.86% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $48,653,000 | +40.6% | 650,000 | +62.5% | 0.86% | +15.7% |
| IKNA | New | IKENA ONCOLOGY INC | $43,774,000 | – | 1,549,513 | +100.0% | 0.77% | – |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $39,945,000 | -24.3% | 1,646,517 | 0.0% | 0.71% | -37.7% | |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $38,714,000 | +49.7% | 525,000 | +75.0% | 0.68% | +23.2% |
| KRON | KRONOS BIO INC | $38,577,000 | -2.0% | 1,317,954 | 0.0% | 0.68% | -19.3% | |
| KRYS | Buy | KRYSTAL BIOTECH INC | $38,520,000 | +170.3% | 500,000 | +110.5% | 0.68% | +122.5% |
| CCXI | Buy | CHEMOCENTRYX INC | $38,430,000 | -4.5% | 750,000 | +15.4% | 0.68% | -21.4% |
| ITOS | ITEOS THERAPEUTICS INC | $37,395,000 | +1.1% | 1,094,047 | 0.0% | 0.66% | -16.8% | |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $37,326,000 | – | 2,255,375 | +100.0% | 0.66% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $37,050,000 | -35.8% | 3,750,000 | +50.0% | 0.66% | -47.1% |
| IMAB | Buy | I MABsponsored ads | $36,353,000 | +6.3% | 750,000 | +3.4% | 0.64% | -12.5% |
| AVGO | New | BROADCOM INC | $34,775,000 | – | 75,000 | +100.0% | 0.61% | – |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $34,325,000 | -9.3% | 2,500,000 | +9.5% | 0.61% | -25.4% |
| BEKE | Sell | KE HLDGS INCsponsored ads | $34,188,000 | -44.4% | 600,000 | -40.0% | 0.60% | -54.3% |
| FCX | New | FREEPORT-MCMORAN INCcall | $32,930,000 | – | 1,000,000 | +100.0% | 0.58% | – |
| CAR | New | AVIS BUDGET GROUP | $32,643,000 | – | 450,000 | +100.0% | 0.58% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $29,578,000 | -30.6% | 312,700 | -10.7% | 0.52% | -42.9% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $29,428,000 | -9.8% | 400,000 | -11.1% | 0.52% | -25.8% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $28,720,000 | -47.7% | 2,000,000 | -28.6% | 0.51% | -57.0% |
| DNLI | Buy | DENALI THERAPEUTICS INC | $28,550,000 | -14.8% | 500,000 | +25.0% | 0.50% | -29.9% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $28,020,000 | +60.6% | 1,000,000 | +100.0% | 0.50% | +32.0% |
| SLB | SCHLUMBERGER LTDcall | $27,190,000 | +24.6% | 1,000,000 | 0.0% | 0.48% | +2.3% | |
| Buy | TRILLIUM THERAPEUTICS INC | $26,850,000 | -13.1% | 2,500,000 | +19.0% | 0.47% | -28.5% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $24,570,000 | -40.5% | 750,000 | 0.0% | 0.43% | -51.0% | |
| REPL | Buy | REPLIMUNE GROUP INC | $24,408,000 | -8.6% | 800,000 | +14.3% | 0.43% | -24.8% |
| VOR | New | VOR BIOPHARMA INC | $23,705,000 | – | 550,000 | +100.0% | 0.42% | – |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $23,664,000 | -12.7% | 2,400,000 | -4.0% | 0.42% | -28.2% |
| NEXI | New | NEXIMMUNE INC | $22,896,000 | – | 1,200,000 | +100.0% | 0.40% | – |
| NG | NOVAGOLD RES INC | $22,776,000 | -9.4% | 2,600,000 | 0.0% | 0.40% | -25.6% | |
| FHTX | FOGHORN THERAPEUTICS INC | $22,679,000 | -35.0% | 1,720,720 | 0.0% | 0.40% | -46.5% | |
| SQZ | Buy | SQZ BIOTECHNOLOGIES CO | $21,974,000 | -52.8% | 1,606,309 | +0.0% | 0.39% | -61.2% |
| GOSS | GOSSAMER BIO INC | $21,820,000 | -4.3% | 2,358,968 | 0.0% | 0.39% | -21.2% | |
| ALBO | Sell | ALBIREO PHARMA INC | $21,150,000 | -19.5% | 600,000 | -14.3% | 0.37% | -33.7% |
| TSHA | TAYSHA GENE THERAPIES INC | $21,130,000 | -23.5% | 1,040,882 | 0.0% | 0.37% | -37.1% | |
| HARP | Buy | HARPOON THERAPEUTICS INC | $20,920,000 | +57.4% | 1,000,000 | +25.0% | 0.37% | +29.8% |
| CRIS | CURIS INC | $20,430,000 | +38.2% | 1,804,729 | 0.0% | 0.36% | +13.9% | |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $20,456,000 | – | 800,000 | +100.0% | 0.36% | – |
| SELB | SELECTA BIOSCIENCES INC | $20,363,000 | +49.3% | 4,500,000 | 0.0% | 0.36% | +22.9% | |
| NTLA | INTELLIA THERAPEUTICS INC | $20,064,000 | +47.5% | 250,000 | 0.0% | 0.36% | +21.6% | |
| CPNG | New | COUPANG INCcl a | $19,740,000 | – | 400,000 | +100.0% | 0.35% | – |
| MRSN | MERSANA THERAPEUTICS INC | $19,416,000 | -39.2% | 1,200,000 | 0.0% | 0.34% | -50.0% | |
| APTX | Buy | APTINYX INC | $18,349,000 | +112.0% | 6,116,493 | +144.5% | 0.32% | +74.2% |
| BLU | BELLUS HEALTH INC NEW | $18,240,000 | +25.5% | 4,750,000 | 0.0% | 0.32% | +3.2% | |
| IQ | Buy | IQIYI INCsponsored ads | $17,036,000 | +14.7% | 1,025,000 | +20.6% | 0.30% | -5.6% |
| KURA | KURA ONCOLOGY INC | $16,962,000 | -13.4% | 600,000 | 0.0% | 0.30% | -28.7% | |
| RPTX | Sell | REPARE THERAPEUTICS INC | $16,880,000 | -13.7% | 550,000 | -3.5% | 0.30% | -29.0% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $16,560,000 | +7.1% | 750,000 | +50.0% | 0.29% | -11.7% |
| TBIO | Sell | TRANSLATE BIO INC | $16,490,000 | -25.4% | 1,000,000 | -16.7% | 0.29% | -38.7% |
| AGEN | Sell | AGENUS INC | $16,320,000 | -25.6% | 6,000,000 | -13.0% | 0.29% | -38.9% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $15,400,000 | -27.8% | 250,000 | -16.7% | 0.27% | -40.6% |
| KWEB | New | KRANESHARES TRcall | $15,270,000 | – | 200,000 | +100.0% | 0.27% | – |
| NBTX | NANOBIOTIX SAsponsored ads | $15,040,000 | -8.8% | 1,000,000 | 0.0% | 0.27% | -24.9% | |
| ADAG | New | ADAGENE INCads | $14,360,000 | – | 800,000 | +100.0% | 0.25% | – |
| ZYME | Buy | ZYMEWORKS INC | $14,211,000 | -14.1% | 450,000 | +28.6% | 0.25% | -29.3% |
| RLAY | RELAY THERAPEUTICS INC | $13,828,000 | -16.8% | 400,000 | 0.0% | 0.24% | -31.7% | |
| SANA | New | SANA BIOTECHNOLOGY INC | $13,388,000 | – | 400,000 | +100.0% | 0.24% | – |
| YI | Sell | 111 INCads | $13,336,000 | +91.9% | 966,349 | -3.4% | 0.24% | +58.4% |
| ORTX | Buy | ORCHARD THERAPEUTICS PLCads | $13,096,000 | +762.7% | 1,803,858 | +413.2% | 0.23% | +600.0% |
| Z | Sell | ZILLOW GROUP INCcl c cap stk | $12,964,000 | -81.8% | 100,000 | -81.8% | 0.23% | -85.1% |
| AUPH | AURINIA PHARMACEUTICALS INC | $12,985,000 | -6.1% | 1,000,000 | 0.0% | 0.23% | -22.9% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $12,664,000 | -31.8% | 400,000 | 0.0% | 0.22% | -43.7% | |
| SLDB | New | SOLID BIOSCIENCES INC | $12,443,000 | – | 2,250,000 | +100.0% | 0.22% | – |
| Buy | MARINUS PHARMACEUTICALS INC | $12,384,000 | +238.4% | 800,000 | +166.7% | 0.22% | +177.2% | |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $12,096,000 | -14.3% | 400,000 | +40.3% | 0.21% | -29.4% |
| DSGN | New | DESIGN THERAPEUTICS INC | $11,960,000 | – | 400,000 | +100.0% | 0.21% | – |
| BMRN | BIOMARIN PHARMACEUTICAL INCcall | $11,327,000 | -13.9% | 150,000 | 0.0% | 0.20% | -29.1% | |
| TIL | New | INSTIL BIO INC | $11,286,000 | – | 450,000 | +100.0% | 0.20% | – |
| TME | New | TENCENT MUSIC ENTMT GROUPsponsored ads | $11,270,000 | – | 550,000 | +100.0% | 0.20% | – |
| IMUX | IMMUNIC INC | $11,158,000 | +4.3% | 700,000 | 0.0% | 0.20% | -14.3% | |
| EVLO | Buy | EVELO BIOSCIENCES INC | $10,700,000 | +26.4% | 1,000,000 | +42.9% | 0.19% | +3.8% |
| OVID | OVID THERAPEUTICS INC | $10,050,000 | +74.0% | 2,500,000 | 0.0% | 0.18% | +43.5% | |
| TCOM | Sell | TRIP COM GROUP LTDads | $9,908,000 | -41.3% | 250,000 | -50.0% | 0.18% | -51.7% |
| STOK | STOKE THERAPEUTICS INC | $9,710,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.2% | |
| KYMR | KYMERA THERAPEUTICS INC | $9,715,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.3% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $8,968,000 | -68.6% | 200,000 | -60.0% | 0.16% | -74.2% |
| OLMA | OLEMA PHARMACEUTICALS INC | $8,643,000 | -31.0% | 260,500 | 0.0% | 0.15% | -43.1% | |
| ARAV | ARAVIVE INC | $8,641,000 | +16.8% | 1,311,291 | 0.0% | 0.15% | -3.8% | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $8,514,000 | – | 200,000 | +100.0% | 0.15% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $8,276,000 | +0.6% | 1,045,000 | 0.0% | 0.15% | -17.5% | |
| DYN | Buy | DYNE THERAPEUTICS INC | $8,153,000 | +29.4% | 525,000 | +75.0% | 0.14% | +6.7% |
| GDS | Sell | GDS HLDGS LTDsponsored ads | $8,109,000 | -91.3% | 100,000 | -90.0% | 0.14% | -92.9% |
| HOOK | Sell | HOOKIPA PHARMA INC | $8,065,000 | -23.4% | 599,616 | -36.9% | 0.14% | -37.2% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $7,667,000 | -5.8% | 1,025,000 | +36.7% | 0.14% | -22.9% |
| ACIU | AC IMMUNE SA | $7,610,000 | +47.2% | 1,000,000 | 0.0% | 0.13% | +20.7% | |
| APLT | Buy | APPLIED THERAPEUTICS INC | $7,502,000 | -10.3% | 400,000 | +5.3% | 0.13% | -26.1% |
| OMEG | New | OMEGA ALPHA SPACcl a | $7,425,000 | – | 750,000 | +100.0% | 0.13% | – |
| SPRO | SPERO THERAPEUTICS INC | $7,360,000 | -24.1% | 500,000 | 0.0% | 0.13% | -37.5% | |
| CFRX | Buy | CONTRAFECT CORP | $7,200,000 | +42.6% | 1,500,000 | +50.0% | 0.13% | +17.6% |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $6,945,000 | -57.1% | 750,000 | -16.7% | 0.12% | -64.7% |
| ALPN | ALPINE IMMUNE SCIENCES INC | $6,286,000 | -15.9% | 593,030 | 0.0% | 0.11% | -30.6% | |
| SGTX | SIGILON THERAPEUTICS INC | $6,169,000 | -53.5% | 276,000 | 0.0% | 0.11% | -61.8% | |
| FUSN | New | FUSION PHARMACEUTICALS INC | $5,781,000 | – | 539,264 | +100.0% | 0.10% | – |
| LPTX | LEAP THERAPEUTICS INC | $5,700,000 | -15.6% | 3,000,000 | 0.0% | 0.10% | -30.3% | |
| MTCR | METACRINE INC | $5,734,000 | -21.1% | 924,898 | 0.0% | 0.10% | -35.3% | |
| CYCN | CYCLERION THERAPEUTICS INC | $5,071,000 | -8.8% | 1,817,584 | 0.0% | 0.09% | -24.4% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $5,055,000 | – | 1,500,000 | +100.0% | 0.09% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $4,167,000 | – | 100,000 | +100.0% | 0.07% | – |
| MCRB | SERES THERAPEUTICS INC | $4,118,000 | -16.0% | 200,000 | 0.0% | 0.07% | -30.5% | |
| KLDO | KALEIDO BIOSCIENCES INC | $4,054,000 | -11.0% | 500,500 | 0.0% | 0.07% | -26.5% | |
| YMTX | YUMANITY THERAPEUTICS INC | $3,935,000 | +6.5% | 217,391 | 0.0% | 0.07% | -11.4% | |
| KNTE | KINNATE BIOPHARMA INC | $3,895,000 | -21.7% | 125,000 | 0.0% | 0.07% | -35.5% | |
| SHLS | New | SHOALS TECHNOLOGIES GROUP INcl a | $3,478,000 | – | 100,000 | +100.0% | 0.06% | – |
| AXLA | AXCELLA HEALTH INC | $3,392,000 | -8.3% | 712,500 | 0.0% | 0.06% | -24.1% | |
| RNA | AVIDITY BIOSCIENCES INC | $3,108,000 | -14.5% | 142,500 | 0.0% | 0.06% | -29.5% | |
| VIAC | New | VIACOMCBS INCcl b | $3,044,000 | – | 67,500 | +100.0% | 0.05% | – |
| LVTX | New | LAVA THERAPEUTICS NV | $3,038,000 | – | 200,000 | +100.0% | 0.05% | – |
| CDAK | New | CODIAK BIOSCIENCES INC | $3,016,000 | – | 200,000 | +100.0% | 0.05% | – |
| KDNY | CHINOOK THERAPEUTICS INC | $2,805,000 | -2.0% | 180,500 | 0.0% | 0.05% | -18.0% | |
| MEIP | MEI PHARMA INC | $2,607,000 | +30.0% | 760,000 | 0.0% | 0.05% | +7.0% | |
| XLE | SELECT SECTOR SPDR TRcall | $2,453,000 | +29.4% | 50,000 | 0.0% | 0.04% | +4.9% | |
| ORIC | ORIC PHARMACEUTICALS INC | $2,450,000 | -27.6% | 100,000 | 0.0% | 0.04% | -41.1% | |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $1,943,000 | -27.5% | 75,000 | -43.6% | 0.03% | -41.4% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,236,000 | -1.7% | 110,532 | 0.0% | 0.02% | -18.5% | |
| CHMA | CHIASMA INC | $1,189,000 | -28.1% | 380,000 | 0.0% | 0.02% | -40.0% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,098,000 | -2.3% | 321,100 | 0.0% | 0.02% | -20.8% | |
| SURF | SURFACE ONCOLOGY INC | $780,000 | -15.6% | 100,000 | 0.0% | 0.01% | -30.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $598,000 | +33.2% | 224,675 | 0.0% | 0.01% | +10.0% | |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $343,000 | -23.8% | 79,600 | 0.0% | 0.01% | -40.0% | |
| MANU | New | MANCHESTER UTD PLC NEWord cl a | $197,000 | – | 12,488 | +100.0% | 0.00% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -129,335 | -100.0% | -0.04% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.04% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -95,000 | -100.0% | -0.06% | – |
| PRQR | Exit | PROQR THERAPEUTICS N V | $0 | – | -1,196,218 | -100.0% | -0.11% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -50,000 | -100.0% | -0.11% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -400,000 | -100.0% | -0.15% | – |
| AAL | Exit | AMERICAN AIRLS GROUP INCcall | $0 | – | -500,000 | -100.0% | -0.17% | – |
| BRKR | Exit | BRUKER CORP | $0 | – | -175,275 | -100.0% | -0.20% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -500,000 | -100.0% | -0.22% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -50,000 | -100.0% | -0.24% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -400,000 | -100.0% | -0.32% | – |
| TECH | Exit | BIO-TECHNE CORP | $0 | – | -60,000 | -100.0% | -0.41% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -1,000,000 | -100.0% | -0.50% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -700,000 | -100.0% | -0.54% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.56% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -200,000 | -100.0% | -1.00% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -200,000 | -100.0% | -1.00% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -800,000 | -100.0% | -1.84% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.